251 related articles for article (PubMed ID: 25915157)
21. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
22. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.
Meads MB; Hazlehurst LA; Dalton WS
Clin Cancer Res; 2008 May; 14(9):2519-26. PubMed ID: 18451212
[TBL] [Abstract][Full Text] [Related]
23. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
[TBL] [Abstract][Full Text] [Related]
24. Inoculation of human tumor cells alters the basal expression but not the inducibility of cytochrome P450 enzymes in tumor-bearing mouse liver.
Sugawara M; Okamoto K; Kadowaki T; Kusano K; Fukamizu A; Yoshimura T
Drug Metab Dispos; 2009 Nov; 37(11):2244-54. PubMed ID: 19666990
[TBL] [Abstract][Full Text] [Related]
25. Expressions of cytochrome P450, UDP-glucuronosyltranferase, and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice.
Sugawara M; Okamoto K; Kadowaki T; Kusano K; Fukamizu A; Yoshimura T
Drug Metab Dispos; 2010 Mar; 38(3):526-33. PubMed ID: 20007293
[TBL] [Abstract][Full Text] [Related]
26. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.
Morton JJ; Bird G; Keysar SB; Astling DP; Lyons TR; Anderson RT; Glogowska MJ; Estes P; Eagles JR; Le PN; Gan G; McGettigan B; Fernandez P; Padilla-Just N; Varella-Garcia M; Song JI; Bowles DW; Schedin P; Tan AC; Roop DR; Wang XJ; Refaeli Y; Jimeno A
Oncogene; 2016 Jan; 35(3):290-300. PubMed ID: 25893296
[TBL] [Abstract][Full Text] [Related]
27. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
28. Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Wobus M; Benath G; Ferrer RA; Wehner R; Schmitz M; Hofbauer LC; Rauner M; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2012 Oct; 40(10):867-76. PubMed ID: 22705469
[TBL] [Abstract][Full Text] [Related]
29. Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them.
Guo Z; Johnson V; Barrera J; Porras M; Hinojosa D; Hernández I; McGarrah P; Potter DA
Cancer Metastasis Rev; 2018 Sep; 37(2-3):409-423. PubMed ID: 30066055
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells.
Yao H; Miura Y; Yoshioka S; Miura M; Hayashi Y; Tamura A; Iwasa M; Sato A; Hishita T; Higashi Y; Kaneko H; Ashihara E; Ichinohe T; Hirai H; Maekawa T
Stem Cells; 2014 Aug; 32(8):2245-55. PubMed ID: 24648356
[TBL] [Abstract][Full Text] [Related]
31. SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.
Otte A; Yang Y; von der Ohe J; Melzer C; Hillemanns P; Feuerhake F; Hass R
Int J Oncol; 2016 Dec; 49(6):2453-2463. PubMed ID: 27748897
[TBL] [Abstract][Full Text] [Related]
32. P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.
Azab AK; Quang P; Azab F; Pitsillides C; Thompson B; Chonghaile T; Patton JT; Maiso P; Monrose V; Sacco A; Ngo HT; Flores LM; Lin CP; Magnani JL; Kung AL; Letai A; Carrasco R; Roccaro AM; Ghobrial IM
Blood; 2012 Feb; 119(6):1468-78. PubMed ID: 22096244
[TBL] [Abstract][Full Text] [Related]
33. PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.
Zheng Y; Yang J; Qian J; Qiu P; Hanabuchi S; Lu Y; Wang Z; Liu Z; Li H; He J; Lin P; Weber D; Davis RE; Kwak L; Cai Z; Yi Q
Leukemia; 2013 Mar; 27(3):702-10. PubMed ID: 22996336
[TBL] [Abstract][Full Text] [Related]
34. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Hsieh YT; Gang EJ; Geng H; Park E; Huantes S; Chudziak D; Dauber K; Schaefer P; Scharman C; Shimada H; Shojaee S; Klemm L; Parameswaran R; Loh M; Kang ES; Koo HH; Hofmann WK; Andrade J; Crooks GM; Willman CL; Müschen M; Papayannopoulou T; Heisterkamp N; Bönig H; Kim YM
Blood; 2013 Mar; 121(10):1814-8. PubMed ID: 23319569
[TBL] [Abstract][Full Text] [Related]
35. Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids.
Hernandez D; Palau L; Norsworthy K; Anders NM; Alonso S; Su M; Petkovich M; Chandraratna R; Rudek MA; Smith BD; Jones RJ; Ghiaur G
Leukemia; 2020 Nov; 34(11):3077-3081. PubMed ID: 32152463
[No Abstract] [Full Text] [Related]
36. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
[TBL] [Abstract][Full Text] [Related]
37. Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.
Chen Y; Jacamo R; Shi YX; Wang RY; Battula VL; Konoplev S; Strunk D; Hofmann NA; Reinisch A; Konopleva M; Andreeff M
Blood; 2012 May; 119(21):4971-80. PubMed ID: 22490334
[TBL] [Abstract][Full Text] [Related]
38. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
39. Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction.
Wang JY; Yu P; Chen S; Xing H; Chen Y; Wang M; Tang K; Tian Z; Rao Q; Wang J
Mol Oncol; 2013 Oct; 7(5):907-16. PubMed ID: 23726395
[TBL] [Abstract][Full Text] [Related]
40. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer.
Cheah MT; Chen JY; Sahoo D; Contreras-Trujillo H; Volkmer AK; Scheeren FA; Volkmer JP; Weissman IL
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4725-30. PubMed ID: 25825750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
